-
1
-
-
0018899177
-
Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemothera-py-inducedemesis
-
Steele N, Gralla RJ, Braun DW, et al: Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemothera-py-inducedemesis, CancerTrcat Rep 1980:64: 219-224.
-
(1980)
Cancertrcat Rep
, vol.64
, pp. 219-224
-
-
Steele, N.1
Gralla, R.J.2
Braun, D.W.3
-
2
-
-
0019502642
-
Antiemctic efficacy of high-dose mctoclopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting
-
Gralla RJ, Itri LM, Pisko SE, et al: Antiemctic efficacy of high-dose mctoclopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting, N Engl J Med 1981:305: 905-909.
-
(1981)
N Engl J Med
, vol.305
, pp. 905-909
-
-
Gralla, R.J.1
Itri, L.M.2
Pisko, S.E.3
-
3
-
-
0343005310
-
Double-blind placebo-controlled study of metoclopramide in cisplatin-induced emesis
-
Homesley HD, Gayney JM, Jobscn VN, et al: Double-blind placebo-controlled study of metoclopramide in cisplatin-induced emesis, N Engl J Med 1982:307:250-251.
-
(1982)
N Engl J Med
, vol.307
, pp. 250-251
-
-
Homesley, H.D.1
Gayney, J.M.2
Jobscn, V.N.3
-
4
-
-
0029816125
-
Optimal control of acute cisplatin-induced emesis
-
Verwcij J, De Wit R, De Mulder PHM: Optimal control of acute cisplatin-induced emesis, Oncology 1996;53(suppl 1):56-64.
-
(1996)
Oncology
, vol.53
, pp. 56-64
-
-
Verwcij, J.1
De Wit, R.2
De Mulder, P.3
-
5
-
-
0029033527
-
Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis
-
5a Navari R, Gandara D, Hcsbeth P: Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis, J Clin Oncol 1995:13:1242-1248.
-
(1995)
J Clin Oncol
, vol.13
, pp. 1242-1248
-
-
Navari, R.1
Gandara, D.2
Hcsbeth, P.3
-
6
-
-
0021993784
-
Improved control of cisplatin-induced emesis with high-dose mctoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine: Results of consecutive trials in 255 patients
-
5b Kris MG, Gralla RJ, Tyson LB, et al: Improved control of cisplatin-induced emesis with high-dose mctoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine: Results of consecutive trials in 255 patients, Cancer 1985:55:527-534.
-
(1985)
Cancer
, vol.55
, pp. 527-534
-
-
Kris, M.G.1
Gralla, R.J.2
Tyson, L.B.3
-
7
-
-
0026071703
-
Prevention of cisplatin-induced emesis: A double-blind multiccntcr randomized crossover study comparing ondansetron and ondansetron plus dexamethasone
-
Roila F, Tonato M, Cognctti F, et al: Prevention of cisplatin-induced emesis: A double-blind multiccntcr randomized crossover study comparing ondansetron and ondansetron plus dexamethasone, J Clin Oncol 1991;9:674-678.
-
(1991)
J Clin Oncol
, vol.9
, pp. 674-678
-
-
Roila, F.1
Tonato, M.2
Cognctti, F.3
-
8
-
-
0028888664
-
Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer
-
Roila F: Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer, N Engl J Med 1995;332:1-6.
-
(1995)
N Engl J Med
, vol.332
, pp. 1-6
-
-
Roila, F.1
-
9
-
-
0000666741
-
Contribution of dexamethasone to antiemctic control with granisetron is greatest in patients at high risk of emesis
-
Dilly SG, Friedman C, Yocom K: Contribution of dexamethasone to antiemctic control with granisetron is greatest in patients at high risk of emesis, Proc Am Soc Clin Oncol 1994:13:436.
-
(1994)
Proc am Soc Clin Oncol
, vol.13
, pp. 436
-
-
Dilly, S.G.1
Friedman, C.2
Yocom, K.3
-
10
-
-
0029839763
-
Control of acute cisplatin-induced emesis over repeated courscs of chemotherapy
-
on behalf of the Italian Group for Antiemetic Research
-
Roila F, on behalf of the Italian Group for Antiemetic Research: Control of acute cisplatin-induced emesis over repeated courscs of chemotherapy, Oncology 1996;53(suppl 1):65- 72.
-
(1996)
Oncology
, vol.53
-
-
Roila, F.1
-
11
-
-
0029813534
-
Management of cisplatin-induced delayed emesis
-
Hesketh P: Management of cisplatin-induced delayed emesis, Oncology 1996;53(suppl 1): 73-77.
-
(1996)
Oncology
, vol.53
, pp. 73-77
-
-
Hesketh, P.1
-
12
-
-
0030171191
-
5-HTj receptor antagonists in the control of cisplatin-induced delayed emesis
-
Ossi M, Anderson E, Freeman A: 5-HTj receptor antagonists in the control of cisplatin-induced delayed emesis, Oncology 1996; 53(suppl 1):78-85.
-
(1996)
Oncology
, vol.53
, pp. 78-85
-
-
Ossi, M.1
Erson, E.2
Freeman, A.3
-
13
-
-
0021994999
-
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin
-
Kris MG, Gralla RJ, Clark RA, et al: Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin, J Clin Oncol 1985:3:1379- 1384.
-
(1985)
J Clin Oncol
, vol.3
-
-
Kris, M.G.1
Gralla, R.J.2
Clark, R.A.3
-
14
-
-
0024515648
-
Controlling delayed vomiting: Double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramidc plus dcxametha-sonc in patients receiving cisplatin
-
Kris MG, Gralla RJ, Tyson LB, et al: Controlling delayed vomiting: Double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramidc plus dcxametha-sonc in patients receiving cisplatin, J Clin Oncol 1989;7:108-114.
-
(1989)
J Clin Oncol
, vol.7
, pp. 108-114
-
-
Kris, M.G.1
Gralla, R.J.2
Tyson, L.B.3
-
15
-
-
84936034374
-
Antiemctic trials to control delayed vomiting following high-dose cisplatin
-
Clark R, Kris M, Tyson L, et al: Antiemctic trials to control delayed vomiting following high-dose cisplatin, Proc Am Soc Clin Oncol 1986:5:257.
-
(1986)
Proc am Soc Clin Oncol
, vol.5
, pp. 257
-
-
Clark, R.1
Kris, M.2
Tyson, L.3
-
16
-
-
0343440877
-
Management of cisplatin-induced delaycd-onset nausea and vomiting: Preliminary results with 2 drug regimens
-
Strum S, McDcrmed J, Abrahano-Umali R, et al: Management of cisplatin-induced delaycd-onset nausea and vomiting: Preliminary results with 2 drug regimens, Proc Am Soc Clin Oncol 1985:4:263.
-
(1985)
Proc am Soc Clin Oncol
, vol.4
, pp. 263
-
-
Strum, S.1
Mc Dcrmed, J.2
Abrahano-Umali, R.3
-
17
-
-
0025615002
-
Ondansetron compared with high-dose metoclopramidc in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting: A multicenter, randomized, double-blind crossover study
-
De Mulder PHM, Seynaevc C, Vcrmorkcr JB, et al: Ondansetron compared with high-dose metoclopramidc in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting: A multicenter, randomized, double-blind crossover study, Ann Intern Med 1990:113: 834-840.
-
(1990)
Ann Intern Med
, vol.113
, pp. 834-840
-
-
De Mulder, P.1
Seynaevc, C.2
Vcrmorkcr, J.B.3
-
18
-
-
0025489816
-
Ondansetron in the prophylaxis of acute and delayed cisplaiin-induccd emesis
-
Roila F, Bracarda S, Tonato M, et al: Ondansetron in the prophylaxis of acute and delayed cisplaiin-induccd emesis, Clin Oncol 1990:2: 268-272.
-
(1990)
Clin Oncol
, vol.2
, pp. 268-272
-
-
Roila, F.1
Bracarda, S.2
Tonato, M.3
|